DEA

It wasn’t long ago when Ross Gerber, president and CEO of Gerber Kawasaki Wealth and Investment Management and an enthusiastic Tesla Inc (NASDAQ: TSLA) investor, said that the nine things he focuses on in his investment decisions included “things...

Ira Katz’s Little Five Points Pharmacy is one of the dozens of independent drugstores that intended to provide medical marijuana (MMJ) after Georgia became the first and only in the nation to undertake a program of dispensing MMJ in a state where there are only...

In 2022, the farm-level value of total utilized hemp production amounted to $238.4 million, a notable decrease from $824 million in 2021. This encompassed all production types and market segments, with floral hemp dominating in 2022, commanding higher market prices than other hemp products. In the...

The MSOS ETF is now up 41.4% from the August 30, 2023, HHS rescheduling announcement, but it has fallen significantly from its peak gain of 85.0% in mid-September. The Viridian Chart of the Week looks at the potential upside and downside of the top 15 MSOs concerning a DEA announcement on...

A former Food and Drug Administration (FDA) official says he’d be "shocked" if the DEA does not reschedule cannabis by next year's presidential election, and that he expects the DEA will ultimately accept the recent Health and Human Services’ recommendation...

Two political coalitions, the left-leaning Marijuana Justice Coalition and the conservative Cannabis Freedom Alliance have united to urge President Joe Biden to fulfill his campaign promise by removing marijuana from the federal Controlled Substances Act (CSA). The coalition, which includes...

A coalition of 31 bipartisan House members sent a letter to DEA administrator Anne Milgram, urging the agency to consider congressional and state marijuana legalization efforts as it carries out its review into cannabis scheduling, which was recommended by President Biden nearly one year...

The Department of Health and Human Services disclosed a heavily redacted letter sent to the DEA concerning its recommendations for marijuana rescheduling. The exact contents of the message, including the actual scheduling recommendation and an attached scientific review, were withheld. The HHS...

The FBI confirmed this week that cops across the U.S. made nearly a quarter of a million marijuana-related arrests in 2022, during which time cannabis was legal in some form, recreationally or medically, in nearly 38 states. Of these arrests, 92% were for...

This article was originally published on MG Magazine and appears here with permission. In 1988, a federal judge brashly ruled against the Reagan administration’s drug policy and declared cannabis fit for medical use. The controversial decision nearly reclassified marijuana under the...

One of the most important results of the potential rescheduling of cannabis to Schedule 3 is eliminating 280e taxes. In previous charts of the week, we have shown that 280e significantly negatively impacts cannabis companies by reducing their internally funded growth and limiting their debt...

The shortage of stimulant-based ADHD (Attention Deficit Hyperactivity Disorder) medications like Adderall, Vyvanse and Ritalin persists, with leading drug makers unable to provide a solution. The shortage began in Fall 2022 and was exacerbated by record-high prescription rates. Teva...

Congressman Dave Joyce (R-OH), a co-chair of the Congressional Cannabis Caucus, is refining the so-called Strengthening the Tenth Amendment Through Entrusting States (STATES) Act, a bill that would amend the Controlled Substances Act (CSA) to undo federal criminalization of those acting...

The announcement last week by the department of Health and Human Services (HHS) that it is now recommending the rescheduling of cannabis from schedule I to III, marks a significant inflection point for federal cannabis reform. The timing of the Drug Enforcement Agency (DEA...

In an exclusive interview with Benzinga, Carlos Pinto, chief commercial officer (CCO) of Leafly Holdings Inc. (NASDAQ: LFLY) discussed the strategic shift the cannabis marketplace and education platform has undergone. He also shared his perspective on the Department of Health...